2.12
0.08 (3.92%)
Market Trend
Short Term | Medium Term | ||
Industry | Medical Devices (US) | Bullish | Bearish |
Medical Devices (Global) | Bullish | Bearish | |
Stock | Cutera, Inc. | Mixed | Bearish |
Cutera Inc is a medical device company. It specializes in the design, development, manufacture, marketing and servicing of laser and other energy based aesthetics systems for practitioners internationally. Its products include enlighten, excel HR, excel V, Xeo and Trusculpt 3D among others. The company markets and sells its products under the trademarks such as Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis plus, Pico-genesis, Titan, Trusculpt, and Xeo among others. It derives the majority of its revenue from the United States geographic segment. |
|
Sector | Healthcare |
Industry | Medical Devices |
Investment Style | Small Value |
Ownership
Name | Date | Shares Held |
---|---|---|
Voce Capital Management Llc | 30 Jun 2023 | 831,630 |
52 Weeks Range |
1.28 - 23.28
|
|
High | 10.00 (Stephens & Co., 371.70%) | Buy |
Median | 10.00 (371.70%) | |
Average | 10.00 (371.70%) | |
Total | 1 Buy |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Stephens & Co. | 22 Mar 2024 | 10.00 (371.70%) | Buy | 1.60 |
06 Mar 2024 | 10.00 (371.70%) | Buy | 2.11 |
No data within this time range.
Date | Type | Details |
---|---|---|
26 Apr 2024 | Announcement | Cutera to Announce First Quarter Results on May 9, 2024 |
11 Apr 2024 | Announcement | Cutera® Announces the North America Launch of xeo®+ |
21 Mar 2024 | Announcement | Cutera Announces Fourth Quarter and Full-Year 2023 Financial Results Along with 2024 Outlook |
01 Mar 2024 | Announcement | Cutera to Announce Fourth Quarter and Full-Year 2023 Results on March 21, 2024 |
08 Feb 2024 | Announcement | Cutera Announces the International Limited Commercial Release of AviClear® at IMCAS World Congress 2024 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2024 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |